HIGHLIGHTS
- who: Wiebke Sondermann et al. from the Department of Dermatology, University Hospital Essen, West German Cancer Center, University DuisburgEssen and the German Cancer Consortium (DKTK), Essen, Germany have published the research: Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0124590]. April 21, 2015 of December/21,/2014
- what: In this study the extent to which concomitant use of in treated patients affects lymphocyte counts and predisposes to infection was investigated.
- how: The study was conducted in accordance with the principles . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.